Contacts

Transcription

1 Blumenau - SC, November 13 th Cremer (B3: CREM3), a supplier of healthcare products for first aid, surgery, treatment and hygiene, today announced its third quarter 2018 results. The Company's consolidated financial statements have been prepared according to the International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board ("IASB") and according to Brazilian accounting standards ("BR GAAP"), which are based on Brazilian Corporate Law (Lei das Sociedades por Ações) and on CVM regulations. MARKET Close on November 13 th, 2018 CREM3: R$ per share Market cap: R$ million Capital Stock: 32,077,412 shares Contacts acionistas@cremer.com.br Management Comments On October 18 th we disclosed in the B3 S.A. - Brasil, Bolsa Balcão ("B3") OPA (Public Offer for Acquisition), whereby CM Hospitalar S.A. purchased 3,615,649 (three million, six hundred and fifteen thousand six hundred and forty-nine) common shares issued by Cremer S.A., representing about 11.27% of its share capital. The transaction was settled on October 23, at which time CM Hospitalar S.A. now holds 32,010,060 (thirty-two million ten thousand and sixty) common shares issued by Cremer S.A., representing about 99.79% of its share capital. As the OPA was accepted by the representatives of more than 2/3 (two thirds) of the outstanding shares (as defined in item of the OPA Document), it reached the required quorum to cancel registration according to Article 16, II of CVM Instruction 365 of March , as amended ("ICVM 361/02", the Company will proceed with the required cancellation measures and documents, as per CVM Instruction 480 of 7 th December 2009 as amended ( ICVM 480/09 ). Under the terms and conditions of the OPA Document, the owners of the remaining shares that were the object of the OPA may exercise their supervening right to sell; there is a period of up to 3 months (i.e. to January Supervening Acquisition Period) when CM Hospitalar is required to purchase such shares Given that on the date the OPA was settled fewer than 5% of the common shares were outstanding, according to Article 4, Paragraph 4 of Brazilian Corporate Law (Lei das S.A.), and article 20, III of ICVM 361/02 and item 8.5 of the OPA Document, an Extraordinary Shareholder's Meeting was convened on November 9 th tha decided the compulsory purchase of up to all of the common shares still outstanding, following the unified public offer auction to purchase the shares issued by the Company made by CM Hospitalar S.A. due to the sale of control and the cancellation of the company as a traded company ("OPA"); Page 1 of 5

2 Performance in the Quarter Our margins were significantly impacted this quarter, primarily due to (i) an adverse cost scenario, with the US Dollar exchange and the cost of cotton having a negative impact, and (ii) a worsening competitive situation. Our Net Income was influenced by the sale of a piece of land valued at R$ 15 million, otherwise our growth would have been 5.3% compared to 3Q17 Key Financials (R$ x 1,000) Gross Revenue 192, , , , , , , , % 4.5% Net Revenue 162, , , , , , , , % 5.3% Gross Profit 48,791 47,658 54, ,549 48,848 54,215 50, , % 2.2% Gross Margin 30.1% 29.6% 31.9% 30.5% 31.6% 31.6% 26.3% 29.6% -5.6 p.p -0.9 p.p EBITDA 19,184 17,687 24,095 60,966 16,215 18,822 16,418 51, % -15.6% EBITDA Margin 11.8% 11.0% 14.2% 12.4% 10.5% 11.0% 8.5% 9.9% -5.7 p.p -2.5 p.p Net Margin 0.7% 2.2% 3.5% 2.1% 1.3% 1.2% 3.3% 2.0% -0.3 p.p -0.1 p.p Source: Company Management Reports (not reviewed by an independent auditor) EBITDA and Generation of Operating Cash are performance measures used by the Company; they are not a measure of financial performance according to Brazilian GAAP and should not be considered alone, as an alternative to net income to measure of operating performance, as an alternative to operating cash flows, or as a measure of liquidity. We consumed R$ 9.3 million in cash this quarter, primarily due to the building of strategic inventories and customer financing. Operating Cash Flow (R$ x 1,000) Working Capital -10,779 10,541 15,067 14,829-22,644 16,169-14,149-20,624 N/A N/A Depreciation and Amortization 4,753 4,277 3,769 12,799 3,720 4,684 4,695 13, % 2.3% Others -1, , ,436-2,356-2,973-2,893 N/A N/A Operating Cash Flow -6,276 18,608 25,871 38,203-14,453 20,582-6,123 6 N/A % Capex and Intangibles ,257-2,449-3,954-6,301-9,492-3,456-19, % 386.8% Recept of dividends and interest on equity N/A N/A Acquisition and Strategic Partnerships N/A N/A Investing Cash Flow ,257-2,449-3,954-6,301-9,492-3,456-19, % 386.8% Debt 13,451 18,127-1,766 29,812 9,110-63,782 51,561-3,111 N/A N/A Capital Increase/Dividends payment or receipt/interest o ,157 2,974-2,397 4, , % -13.2% Gains on derivatives , ,016 N/A N/A Goodwill on acquisition of equity N/A N/A Share Buyback Program N/A N/A Financing Cash Flow 13,857 18, ,785 6,713-56,789 51,561 1, % -95.5% Increase (Decrease) Cash Position 7,333 35,889 23,812 67,034-14,041-45,699 41,982-17, % % Cash BOP 62,209 69, ,431 62, , ,111 65, , % 101.2% Cash EOP 69, , , , ,111 65, , , % -16.9% Gross Debt EOP 316, , , , , , , , % -9.6% Net Debt EOP -247, , , , , , , , % -5.0% LTM EBITDA 83,673 81,892 82,612 82,612 73,243 74,378 66,701 66, % -19.3% Net / Debt EBITDA % 17.6% Source: Company Management Reports (not reviewed by an independent auditor) EBITDA and Generation of Operating Cash are performance measures used by the Company; they are not a measure of financial performance according to Brazilian GAAP and should not be considered alone, as an alternative to net income to measure of operating performance, as an alternative to operating cash flows, or as a measure of liquidity. Page 2 of 5

3 Statement of Earnings Income Statement ( R$ x 1,000) Gross Revenue from Sales 192, , , , , , , , % 4.5% Sales of Goods or Services 192, , , , , , , , % 4.5% Deductions from Gross Revenue -30,071-31,787-29,590-91,448-30,871-28,872-31,661-91, % 0.0% Sales taxes and deductions on sales -30,071-31,787-29,590-91,448-30,871-28,872-31,661-91, % 0.0% Net Revenue from Sales 162, , , , , , , , % 5.3% Cost of Goods Sold -113, , , , , , , , % 6.7% Gross Profit 48,791 47,658 54, ,549 48,848 54,215 50, , % 2.2% Operating Income (Expenses) -46,912-44,497-44, ,235-44,070-48,410-46, , % 1.9% Selling Expenses -22,752-24,226-24,700-71,678-25,498-27,656-26,615-79, % 11.3% General and Administrative Expenses -10,939-9,226-8,517-28,682-9,760-12,175-10,358-32, % 12.6% Financial -12,306-10,139-10,955-33,400-7,770-8,469-7,327-23, % -29.4% Financial Income 1,601 2,938 2,601 7,140 8,432 9,578 6,120 24, % 238.0% Interest 1,183 2,133 2,475 5,791 3,435 2, , % 17.1% Exchange Gains ,348 2,222 5,418 9, % % Financial Discounts N/A -28.7% Derivativos ,381 4, ,002 N/A N/A Others % -6.9% Financial Expenses -13,907-13,077-13,556-40,540-16,202-18,047-13,447-47, % 17.7% Interest -11,369-10,623-11,072-33,064-8,776-6,513-6,419-21, % -34.3% Exchange Losses ,645-3,131-8,137-6,094-17, % 955.4% Taxes % -2.3% Derivativos ,056-1, ,986 N/A N/A Others -1,538-1,823-1,987-5,348-1,110-1, , % -40.8% Others Operating Income/(Expenses) ,475-1, ,034-3, % 28.7% Operating Income 1,879 3,161 9,274 14,314 4,778 5,805 4,452 15, % 5.0% Income Tax and Social Contribution Provision -1, ,995-4,180-2,381-1,388-2,929-6, % 60.2% Deferred Income Tax 445 1,273-1, ,332 4,781 2,087 N/A 383.1% EPS % -4.6% EPS Fully Diluted % -1.4% Page 3 of 5

4 Balance Sheet Balance Sheet (R$ x 1,000) 1Q17 2Q17 3Q17 1Q18 2Q18 3Q18 ASSETS 3Q17 x 3Q18 2Q18 x 3Q18 Current 338, , , , , , % 17.0% Cash and Cash Equivalents (Current) 69, , , ,111 65, , % 64.2% Cash and Cash Equivalents 1,888 2,208 2,840 2,541 2,930 2, % -0.6% Short-term investments 67, , , ,570 62, , % 67.2% Clients (Trade Accounts Receivable) 112, , , , , , % 16.5% Recoverable taxes 31,061 30,771 30,937 20,030 25,599 28, % 13.3% Others receivables 30,384 29,816 29,038 43,907 44,689 28, % -36.8% Inventories 92,639 90,871 92, , , , % 12.5% Others 2,205 1,489 1,620 1,980 1,773 2, % 13.5% Prepaid expenses 2,205 1,489 1,620 1,980 1,773 2, % 13.5% Non-current 282, , , , , , % -1.1% Clients (Trade Accounts Receivable) % -11.1% Deferred income and social contribution tax 41,399 42,671 41,031 39,037 36,704 36, % 0.1% Taxes recoverable ,997 13,649 12, % -5.1% Others 10,089 9,954 9,985 9,929 9,826 8, % -11.8% Investment 15,597 15,597 15, % N/A Property, plant and equipment 85,130 83,234 82,390 83,542 82,450 82, % 0.0% Intangibles 129, , , , , , % -0.9% Total Assets 621, , , , , , % 9.1% 1Q17 2Q17 3Q17 1Q18 2Q18 3Q18 LIABILITIES 3Q17 x 3Q18 2Q18 x 3Q18 Current 300, , , , , , % 3.0% Loans and financing 31,511 28,862 20,327 54,717 48,156 49, % 3.6% Suppliers 81,482 68,284 83,093 87, , , % 1.1% Debentures 142, , , ,447 86,722 90, % 4.1% Taxes and contributions 11,844 8,723 8,116 10,207 6,938 7, % 1.9% Proposed dividens 2,624 2,624 2,624 4,777 4,777 4, % 0.0% Valores a pagar - Derivativos Provisions 16,770 19,907 20,483 24,276 17,890 20, % 16.8% Vacations and 13rd salary 10,775 13,117 14,896 11,663 13,899 15, % 12.4% Profit Participation 549 1,601 1,293 8, , % 573.6% Others 5,446 5,189 4,294 4,360 3,794 3, % 3.8% Others 13,808 30,751 37,458 37,681 38,997 38, % -0.4% Wage and charge 6,625 6,426 6,954 7,152 7,085 7, % 6.7% Others 7,183 24,325 30,504 30,529 31,912 31, % -2.0% Non-current Liabilities 165, , , , , , % 30.1% Loans and Financing 23,158 13,796 10,665 29,461 41,965 87, % 109.4% Debentures 119, , , ,570 71,704 71, % 0.1% Reserve for contingencies 8,418 8,668 10,038 11,357 12,049 12, % 5.9% Tax 2,582 2,335 1,955 1,527 1,486 1, % -2.8% Diferred Income Tax 11,917 11,916 11,914 11,912 11,910 7, % -39.9% Others % -64.6% Shareholders Equity 154, , , , , , % 3.4% Capital 96,094 96, , , , , % 0.0% Capital reserves 3,694 4,634 1,822 2, % N/A Treasury Shares N/A N/A Profit reserves 26,389 25,165 26,479 36,822 36,481 36, % 0.0% Accumulated Profit/Loss 1,069 5,466 10,566 2,035 4,785 19, % 314.7% AAR Adjustment of asset revaluation 27,496 27,070 26,649 25,875 25,551 16, % -34.3% Total Liabilities and Shareholders Equity 621, , , , , , % 9.1% Page 4 of 5

5 Cash Flow Statement of Cash Flow (R$ x 1,000) Subsidiaries and Affiliates Cremer S.A. subsidiaries on September 30 th, 2018 were: Cremer Administradora de Bens Ltda. (95.27% direct and 4.73% indirect); Embramed Indústria e Comércio de Produtos Hospitalares Ltda. (99.99% direct and 0.01% indirect). CVM Instruction 381/03 To comply with CVM Instruction # 381/03 we state that in third quarter of 2018, we did not retain KPMG Auditores Independentes for any services other than the quarterly review and audit of the company's financial statements. Legal Notice 1Q17 2Q17 3Q17 9M17 1Q18 2Q18 3Q18 Variation 3Q17 x 3Q18 The statements contained herein related to business outlook projections of operating and financial results and those related to the growth outlook for Cremer S.A. are merely projections and, as such, are based exclusively on the expectations of management about future business. These expectations depend substantially on market conditions, the performance of the Brazilian economy, the industry and international markets and are subject to change without notice. The information in this report is not intended as, and should not be interpreted as, a guarantee of the company s performance or future earnings. Variation 9M17 x 9M18 Operating Cash Flow Net income for the period 1,069 3,504 5,993 10,566 2,035 2,085 6, % -1.3% Adjustments to reconcile net income from Operating Activities: Depreciation and amortization 4,753 4,277 3,769 12,799 3,720 4,684 4, % 2.3% Others -1, , ,436-2,356-2, % % Decrease (Increase) in clients 9,950 3,322-6,736 6,536-8,672 12,032-17, % % Decrease (Increase) in inventories 6,037 1,748-1,210 6,575-4,012-14,164-14, % % Decrease (Increase) in other credits 1,399 1, , ,795 13, % 138.2% Decrease (Increase) in non-current assets , % 272.0% Increase (Decrease) in liabilities: Increase (decrease) in suppliers -31,154-13,198 14,808-29,544-12,284 22,790 1, % % Increase (decrease) in tax liabilities 2,998-3, ,005 2,240-3, % -4.2% Increase (decrease) in labor legislation liabilities 938 2,144 2,307 5,389 1,588 2,169 2, % 10.5% Increase (decrease) in other payable/provisions -1,153 18,101 6,133 23,081-1,058 1, % % Net cash generated from operating activities -6,276 18,608 25,871 38,203-14,453 20,582-6, % % Net Cash from Financiang Activities Capital Increase ,157 2, , % 68.9% New loans 8,823 1, ,735 9,474 50,143 54,569 N/A 963.7% Payment of loans -5,740-14,057-10,626-30,423-7,511-45,873-8, % 102.8% Mutual Receipt ,016 0 N/A N/A Financial charges and monetary variations 10,368-9,728 8,860 9,500 7,147-12,052 5, % -95.7% Repurchase of shares % % Payment of dividends and interest on equity , N/A N/A Debenture 0 40, , ,000 0 N/A % Net cash used from financing activities 13,857 18, ,785 6,713-56,789 51, % -95.5% Cash Flow from investiments Capex and intaginble ,257-2,449-3,954-6,301-9,492-3, % 386.8% Net cash used from investments ,257-2,449-3,954-6,301-9,492-3, % 386.8% INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 7,333 35,889 23,812 67,034-14,041-45,699 41, % % Opening balance of cash and cash equivalents 62,209 69, ,431 62, , ,111 65, % 101.2% Closing balance of cash and equivalents 69, , , , ,111 65, , % -16.9% Page 5 of 5